Bioprocessing Supplies Market Global Report 2026

The bioprocessing supplies market size has grown steadily in recent years. It will grow from $10.31 billion in 2025 to $10.73 billion in 2026 at a compound annual growth rate (CAGR) of 4%. The growth in the historic period can be attributed to growth in biologics and vaccine production requiring high purity consumables, increasing adoption of disposable bioprocess systems in manufacturing, expansion of pharmaceutical outsourcing to contract manufacturing organizations, rising focus on contamination free production environments, development of standardized good manufacturing practice guidelines for bioprocess materials.

The bioprocessing supplies market size is expected to see steady growth in the next few years. It will grow to $12.35 billion in 2030 at a compound annual growth rate (CAGR) of 3.6%. The growth in the forecast period can be attributed to increasing demand for personalized medicine and advanced biologics production, expansion of cell and gene therapy manufacturing pipelines requiring specialized consumables, rising investments in localized biomanufacturing supply chains, growing need for sustainable and recyclable bioprocess materials, increasing global demand for scalable single use technologies in industrial bioproduction. Major trends in the forecast period include standardization of single use consumables to ensure consistent bioprocess quality, increasing demand for pre sterilized and gamma irradiated bioprocess materials, expansion of cold chain compatible bioprocess supplies for temperature sensitive biologics, rising adoption of regulatory compliant disposable packaging systems for contamination prevention, growing localization of raw material sourcing for bioprocess consumables to reduce supply disruption risks.

The increasing demand for biologics and biosimilars is expected to propel the growth of the bioprocessing supplies market going forward. Biologics refer to complex drugs derived from living organisms, while biosimilars are highly similar follow-on versions developed after the original biologic's patent expires. The increasing demand for biologics and biosimilars is driven by the rising burden of chronic and complex diseases, which require highly targeted and effective treatments that conventional drugs often cannot provide. Bioprocessing supplies support biologics and biosimilars by enabling sterile, scalable, and controlled manufacturing processes that ensure consistent quality, safety, and efficiency in the production of complex biologic molecules. For instance, in January 2023, according to Cardinal Health Inc., a US-based healthcare company, as of January 2022, the US had 33 biosimilar products approved by the FDA, with 21 available on the market. By 2023, the number of FDA-approved biosimilars increased to 40, with 25 commercially available. Therefore, the increasing demand for biologics and biosimilars is driving the growth of the bioprocessing supplies market.

Key companies operating in the bioprocessing supplies market are focusing on developing advanced purification resins to improve manufacturing productivity, increase purification efficiency, and reduce production costs for biologics. Purification resins are specialized chromatography materials used in downstream bioprocessing to isolate and purify therapeutic proteins, monoclonal antibodies, and other biopharmaceutical products from complex biological mixtures. For example, in June 2025, Ecolab Life Sciences, a US-based provider of life sciences and bioprocessing solutions, launched the Purolite AP+50 affinity chromatography resin at BIO 2025. The new resin features a 50-micron bead size, high dynamic binding capacity, and patented jetted resin bead manufacturing technology, enabling enhanced monoclonal antibody capture, improved process consistency, and shorter lead times. The innovation is designed to optimize antibody manufacturing operations, support process intensification strategies, and help biopharmaceutical manufacturers reduce costs while maintaining product purity and supply chain reliability.

In December 2025, Tetra Pak International SA, a Switzerland-based food packaging and processing company, acquired Bioreactors.net for an undisclosed amount. Through this acquisition, Tetra Pak aims to strengthen its bioreactor and fermentation technology capabilities to accelerate the industrial-scale production of new food solutions, particularly in precision fermentation and biomass-based protein systems, while enabling faster scale-up from laboratory and pilot stages to full commercial manufacturing. Bioreactors.net is a Latvia-based biotechnology engineering company that provides bioprocessing supplies.

Major companies operating in the bioprocessing supplies market are Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Compagnie de Saint-Gobain; Asahi Kasei Corporation; Parker Hannifin Corporation; Avantor Inc.; Sartorius Aktiengesellschaft; FUJIFILM Holdings Corporation; Corning Incorporated; Entegris Inc.; Spirax Group; Bio-Rad Laboratories Inc.; W.L. Gore & Associates; Repligen Corporation; Meissner Filtration Products Inc.; OmniBRx Biotechnologies; Hamilton Company; ABEC Inc.

North America was the largest region in the bioprocessing supplies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocessing supplies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioprocessing supplies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioprocessing supplies market consists of sales of buffer solutions and process liquids, sterilization indicators and validation strips, and pH and conductivity calibration buffers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The bioprocessing supplies market research report is one of a series of new reports that provides bioprocessing supplies market statistics, including bioprocessing supplies industry global market size, regional shares, competitors with a bioprocessing supplies market share, detailed bioprocessing supplies market segments, market trends and opportunities, and any further data you may need to thrive in the bioprocessing supplies industry. This bioprocessing supplies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.